Perrigo Company (Nasdaq:PRGO) hit a new 52-week high Thursday as it is currently trading at $119.75, above its previous 52-week high of $119.51 with 36,421 shares traded as of 10 a.m. ET. Average volume has been 653,800 shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Perrigo Company (Nasdaq: PRGO) hit a new 52-week high Thursday as it is currently trading at $119.75, above its previous 52-week high of $119.51 with 36,421 shares traded as of 10 a.m. ET. Average volume has been 653,800 shares over the past 30 days. Perrigo has a market cap of $11.08 billion and is part of the health care sector and drugs industry. Shares are up 22.5% year to date as of the close of trading on Wednesday. Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API) worldwide. The company has a P/E ratio of 28.3, above the average drugs industry P/E ratio of 27.7 and above the S&P 500 P/E ratio of 17.7.
ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
TheStreet Ratings rates Perrigo as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Perrigo Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.